Surendra Karki։ Examining Blood Type and Coronary Heart Disease Risk in Australian Donors
Surendra Karki, Adjunct Senior Lecturer at Monash University, Adjunct Lecturer at the UNSW School of Public Health and Community Medicine, and Research Fellow at Australian Red Cross Lifeblood, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Excited to share our new publication in Transfusion!
Our study examined over 32,000 Australian blood donors and found a borderline higher risk of coronary heart disease (CHD) among people with blood group AB, compared with group O. Similar results have also been reported in other populations in other countries.
Please note that in our another published study we have shown the act of blood donation itself has no impact on risk of cardiovascular diseases.
A big thank‑you to our collaborators Katy Bell Rena Hirani, Marijke Welvaert David Irving and the 45 and Up Study participants and donors who made this work possible.
Given ABO blood-group is genetically determined, our recommendation for blood donors and others remains to advise regardless of blood type, to follow healthy lifestyle interventions, including not smoking, participating in regular physical activity, having healthy diets, and making regular general practitioner visits to reduce risk of cardiovascular diseases.”
Title: Association of ABO blood group and coronary heart disease in blood donors—Results from a cohort study in Australia
Authors: Surendra Karki, Katy Bell, David O. Irving, Marijke Welvaert, Rena Hirani
Read the Full Article on Transfusion
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 16, 2026, 15:58Alan Nurden: Genome-Wide Analyses Unravel the Genetic Architecture of Coagulation and Fibrinolysis
-
Mar 16, 2026, 15:56Emmanuel J. Favaloro: Latest Publication from Sydney Centres on Heparin Therapy and Monitoring
-
Mar 16, 2026, 15:53Suvro Sankha Datta: Reporting Auto-Anti-Jk Antibodies in Children with Hematological Disorders
-
Mar 16, 2026, 15:44Francis Kynaston-Pearson: Why Randomised Controlled Trials Are the Gold Standard in Clinical Research
-
Mar 16, 2026, 15:18Kalpana Gupta Shekhawat: A Practical Clinical Approach to Iron Regulation
-
Mar 16, 2026, 15:08Mohamed Sikkander Abdul Razak: Warning Signs of Vitamin Deficiencies
-
Mar 16, 2026, 15:05Kate Thomas: Plasma Donations Drive New Era of Life-Saving Medicines in the UK
-
Mar 16, 2026, 14:52Gianluca Franceschini: The Difference in Breast Cancer is Made by the Team
-
Mar 16, 2026, 14:51Heghine Khachatryan: Hematologic Causes of Cryptogenic Stroke